Cargando…
457P The effect of Interleukin-6 (IL-6) on malignancy in COVID-19 patients in Dr. Moewardi General Hospital Surakarta
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719671/ http://dx.doi.org/10.1016/j.annonc.2022.10.487 |
| _version_ | 1784843376422551552 |
|---|---|
| author | Ardianti, M. |
| author_facet | Ardianti, M. |
| author_sort | Ardianti, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9719671 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97196712022-12-05 457P The effect of Interleukin-6 (IL-6) on malignancy in COVID-19 patients in Dr. Moewardi General Hospital Surakarta Ardianti, M. Ann Oncol Article Published by Elsevier Ltd. 2022-11 2022-12-04 /pmc/articles/PMC9719671/ http://dx.doi.org/10.1016/j.annonc.2022.10.487 Text en Copyright © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Ardianti, M. 457P The effect of Interleukin-6 (IL-6) on malignancy in COVID-19 patients in Dr. Moewardi General Hospital Surakarta |
| title | 457P The effect of Interleukin-6 (IL-6) on malignancy in COVID-19 patients in Dr. Moewardi General Hospital Surakarta |
| title_full | 457P The effect of Interleukin-6 (IL-6) on malignancy in COVID-19 patients in Dr. Moewardi General Hospital Surakarta |
| title_fullStr | 457P The effect of Interleukin-6 (IL-6) on malignancy in COVID-19 patients in Dr. Moewardi General Hospital Surakarta |
| title_full_unstemmed | 457P The effect of Interleukin-6 (IL-6) on malignancy in COVID-19 patients in Dr. Moewardi General Hospital Surakarta |
| title_short | 457P The effect of Interleukin-6 (IL-6) on malignancy in COVID-19 patients in Dr. Moewardi General Hospital Surakarta |
| title_sort | 457p the effect of interleukin-6 (il-6) on malignancy in covid-19 patients in dr. moewardi general hospital surakarta |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719671/ http://dx.doi.org/10.1016/j.annonc.2022.10.487 |
| work_keys_str_mv | AT ardiantim 457ptheeffectofinterleukin6il6onmalignancyincovid19patientsindrmoewardigeneralhospitalsurakarta |